Skip to main content
OpenTrials
Completed

NCT Number: NCT07042477

Integrated Telemedicine Program Evaluation

This project will evaluate a virtual, on-demand telemedicine program for High emergency department (ED) utilizers with comorbid physical health conditions and behavioral health correlates. Researchers will randomize patients to have either full access to the full intervention (treatment group) or to receive only standard care (control group). Analyses will be intent-to-treat. The primary outcome is the number of ED visits 120 days after the first Best Practice Alert (BPA) firing.

The research team plans to enroll 3200 patients in this study. However, randomization may end due to system constraints on December 31, 2025 before reaching that target. This sample provides 80% power to detect a 35% relative reduction in ED utilization using a two-tailed test with an alpha of .15, assuming 40% compliance with the program.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Behavioral Intervention Emergency Department Visits Telemedicine

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Geisinger Clinic

Danville, Pennsylvania, 17822, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Patient presents to the ED and meets the following criteria:

Inclusion criteria

  • 18+ years old
  • 4+ Geisinger ED visits in the last 6 months
  • Geisinger Health Plan (GHP) insurance member
  • Has a Geisinger PCP
  • Patient is being seen at one of the following facilities: Geisinger Lewistown Hospital, Geisinger Medical Center, Geisinger Bloomsburg Hospital, Geisinger Jersey Shore Hospital, Geisinger Community Medical Hospital, Geisinger Wyoming Valley, Geisinger Medical Center Muncy, Geisinger Shamokin Ach Hospital, Geisinger South Wilkes Barre

Exclusion criteria

  • Patient being seen in departments determined ineligible by the study team
  • Patient is diagnosed with alcohol and substance-related disorders
  • Patient is going to receive inpatient care
  • Patient is coded in the ED as Level 1 (i.e., seeking life-saving measures)
  • Patient has an Intellectual Disability or Traumatic Brain Injury
  • Patient is actively seeing a BH provider

Treatment and study plan

Integrated Telemedicine Program

Behavioral

The integrated telemedicine program is short-term bridge support provided by a virtually accessible team, including a behavioral health provider (Health Psychologist or Licensed Clinical Social Worker [LCSW]) and Community Health Worker (CHW). Once stabilized, members transition from bridge support to ongoing care with a Geisinger Health System Primary Care Provider and Behavioral Health Provider.

Primary outcomes

  1. Emergency Department Visits

    Time frame: within 120 days of the initial BPA firing

    Number of emergency department visits

Other outcomes

  1. Health-related quality of life (HRQoL)

    Time frame: Within 120 days of randomization

    HRQoL will be measured via the RAND Short Form 36 (36-item questionnaire) administered each BH visit. A high score indicates a better health state or functioning. The lowest and highest possible scores are 0 and 100 respectively.

Sponsors and collaborators

Lead sponsor

Geisinger Clinic

Other

Registry information

Official study title

An Integrated, Virtual and On-Demand Solution to Avoid ED Utilization

Acronym: ITP

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 29, 2025
Registry last updated
Jun 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.